The Brazilian meat company JBS is going to ban the use of the growth hormone ractopamine in pigs in the United States. In this way, the slaughterhouse wants to better respond to sales to China, where the product is banned.
In August last year, JBS stopped administering the product in its own integrations, and from now on the product is also banned from producers who supply their pigs to the slaughterhouse. A spokesperson for JBS says that banning Ractopamine will provide benefits in the long term. Many markets, including China, do not allow the growth hormone to be administered to pigs.
Almost 50% ractopamine-free
JBS is one of the largest pig slaughterhouses in the United States, processing approximately 8 million pigs annually. Together with Smithfield (part of the Chinese WH Group), the company reportedly controls about 40% of the US market. Smithfield has already banned ractopamine at an earlier stage. According to analysts, with JBS's decision, just under 50% of US pig production would now be ractopamine-free.
© DCA Market Intelligence. This market information is subject to copyright. It is not permitted to reproduce, distribute, disseminate or make the content available to third parties for compensation, in any form, without the express written permission of DCA Market Intelligence.